Welcome to our dedicated page for ALLSTATE SEC filings (Ticker: ALL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Allstate Corporation filings document the insurer's operating results, Regulation FD updates, governance matters and registered capital structure. Recent Form 8-K reports include quarterly and annual financial results, investor supplements, estimated catastrophe losses and policies in force for Allstate Protection.
Allstate's proxy materials describe board matters, executive compensation and shareholder voting items. Its filing cover pages identify common stock, fixed-to-floating subordinated debentures due 2053, and depositary shares representing Series H, Series I and Series J noncumulative preferred stock registered on public exchanges.
Allstate Corporation insider plans a small stock sale under Rule 144. The notice covers the proposed sale of 400 shares of common stock of Allstate on the NYSE through Fidelity Brokerage Services LLC. These 400 shares were acquired on 11/17/2025 via an option granted on 02/11/2016, with payment made in cash on the same date. The filing also reports that the same seller, Suren K. Gupta, sold 1,400 shares of common stock on 11/14/2025 for gross proceeds of 301,030.94. Allstate had 261,681,708 shares of common stock outstanding, providing context for the relatively small size of these transactions.
Allstate (ALL): Form 144 notice of proposed sale
A security holder filed to sell 1,400 shares of Allstate common stock under Rule 144. The filing lists an aggregate market value of $301,031.00 and an approximate sale date of 11/14/2025. The planned broker is Fidelity Brokerage Services LLC, and the shares are to be sold on the NYSE.
The filing notes the shares were acquired via options granted on 02/11/2016, with payment on 11/14/2025 in cash. Shares outstanding were 261,681,708, providing baseline context separate from the proposed sale amount.
Allstate Corp: T. Rowe Price Associates, Inc. filed Amendment No. 1 to Schedule 13G reporting beneficial ownership of 12,972,686 Allstate common shares, equal to 4.9% of the class as of 09/30/2025.
The filer reports sole voting power over 12,431,384 shares and sole dispositive power over 12,965,140 shares, with no shared voting or dispositive power. The filing is made in the capacity of an investment adviser under Rule 13d‑1(b), and certifies the securities were acquired and are held in the ordinary course, not to change or influence control. Item 5 indicates ownership of 5 percent or less of the class.
Allstate (ALL) reported stronger quarterly results. For Q3 2025, total revenue was $17.3 billion, up from $16.6 billion a year ago. Net income rose to $3.7 billion from $1.2 billion, and diluted EPS increased to $13.95 from $4.33.
Results benefited from a $720 million gain on disposition of operations, higher net investment income ($949 million vs. $783 million), and lower property and casualty claims and claims expense ($8.7 billion vs. $10.4 billion). Accident and health premiums were lower ($110 million vs. $487 million) as that business continued to shrink.
The balance sheet strengthened, with total assets of $120.4 billion and Allstate shareholders’ equity of $27.5 billion as of September 30, 2025. Accumulated other comprehensive income improved to a $298 million gain. Year-to-date operating cash flow was $7.1 billion, while the company repurchased treasury stock and paid common and preferred dividends. As of October 20, 2025, common shares outstanding were 261,681,708.
The Allstate Corporation (ALL) reported insider activity: Chairman, President & CEO Thomas J. Wilson sold a total of 16,807 shares of common stock on 11/03/2025 through multiple open‑market transactions executed under a Rule 10b5‑1 trading plan adopted on June 27, 2025.
The weighted average sale prices were $188.7305 (5,930 shares), $189.3931 (7,791 shares), $190.4249 (2,101 shares), and $191.3729 (985 shares), with disclosed price ranges for each tranche. Following these sales, Wilson directly beneficially owns 178,426.491 shares.
The Allstate Corporation furnished its third‑quarter 2025 financial results via a Form 8‑K. Under Item 2.02, the company made available a press release and an investor supplement as exhibits, stating these materials are furnished and not filed pursuant to Instruction B.2.
The submission includes Exhibit 99.1 (press release dated November 5, 2025) and Exhibit 99.2 (Third Quarter 2025 Investor Supplement). The filing also lists Allstate’s registered securities and trading symbols on the New York Stock Exchange.
Allstate Corporation (ALL) reported an insider equity transaction. On 11/03/2025, officer Zulfikar Jeevanjee converted 5,110 previously awarded restricted stock units into an equal number of common shares, without payment of consideration, under The Allstate Corporation 2019 Equity Incentive Plan.
On the same date, a separate transaction coded “F” shows the disposition of 2,251 common shares at $191.25 per share. Following these transactions, Jeevanjee directly beneficially owns 10,431 Allstate common shares.
A selling stockholder filed a Form 144 to sell up to 33,614 shares of common stock, with an aggregate market value of $6,428,677.5. The notice lists Goldman Sachs & Co. LLC as broker and an approximate sale date of 11/03/2025 on the NYSE.
The seller is identified as the Thomas J. Wilson Revocable Trust dtd 03/13/15. The filing also reports prior sales over the past three months: 16,807 shares on 10/06/2025 for $3,532,582.66 and 16,807 shares on 10/20/2025 for $3,260,884.06.
Context from the notice shows 263,505,334 shares outstanding and indicates portions of the position were originally acquired as compensation via performance awards on 02/22/2018 and 02/08/2019.
Allstate Corp filed a Form 13F reporting its institutional holdings as of the filing period. The report lists 633 portfolio entries with a total market value of $4,381,321,904 and names 2 other included managers.
The filing is signed by Alexandra Band, Senior Vice President & CFO Investment Finance, and identifies the reporting managers as Allstate Investment Management Co and Allstate Investments LLC. This is a routine quarterly holdings disclosure by an institutional manager.
Allstate (ALL) CEO Thomas J. Wilson reported open-market sales totaling 16,807 shares on 10/20/2025 pursuant to a Rule 10b5-1 trading plan adopted on June 27, 2025. Tranches executed at weighted-average prices of $193.6903, $194.3583, $195.5023, and $196.5001.
After the transactions, he directly owns 195,233.491 Allstate shares. He also reports indirect beneficial holdings, including 111,442 shares by the 2023-B GRAT and 273,954 shares by the 2020 GRAT Remainder Trust.